Only one in five adults can accurately recognize the signs and symptoms of heart failure, according to a new survey commissioned by Abbott (NYSE:ABT). The survey of more than 3,000 Americans revealed a significant gap in awareness of what heart failure is and an understanding of how the disease can be managed. More than six […]
Abbott touts real-world CGM data at diabetes conference
Abbott (NYSE:ABT) said today that new data show its FreeStyle Libre continuous glucose monitoring (CGM) system significantly reduces hemoglobin A1c (HbA1c) levels in certain adults with type 2 diabetes. Presented as a late-breaker at American Diabetes Association (ADA) annual conference in San Francisco, the data represent what Abbott termed the first evaluation of real-world evidence from […]
Report: Healthcare CEO pay balloons to $2.6B, quality of care not a factor in bonuses
Healthcare chief execs at 177 top companies collectively saw their compensation grow to $2.6 billion last year while quality of care and improvements to healthcare spending remained at most a marginal factor to their pay, according to an Axios analysis. Despite a focus on pharmaceutical CEOs, medical device company chief execs were five of the […]
Abbott inks neuroscience research deal with NIH
Abbott (NYSE:ABT) said today that it inked a partnership deal with the National Institutes of Health to support the Brain Research through Advancing Innovative Neurotechnologies, or BRAIN initiative. The NIH’s BRAIN initiative aims to accelerate neuroscience research and advancements, Chicago-area based Abbott said. Through the partnership, Abbott will provide its neuromodulation tech, including directional deep brain […]
Judge: Ex-Abbott worker can’t sue twice
A federal judge in Massachusetts yesterday shot down a second lawsuit brought against Abbott (NYSE:ABT) by a former medical liaison over her claim that the company fired her after she blew the whistle on off-label and pre-approval stent promotion. Ebonia Elliott-Lewis, formerly a regional science manager for Abbott Vascular based in Boston, first sued the company […]
HRS 2019: Study shows no danger to CRM devices from airport body scans
Airport body scanners don’t appear to interfere with pacemakers and defibrillators, and noninvasive neurostimulation through the ear may help treat AFib. Those are but some of the insights coming out of the Heart Rhythm Society’s annual scientific sessions, held this week in San Francisco. Here are some of the research highlights coming out of the […]
UK court shoots down Abbott bid for injunction in TMVR patent spat with Edwards
Edwards Lifesciences (NYSE:EW) recently claimed a win in a UK-based patent spat with Abbott (NYSE:ABT) over IP related to each company’s respective transcatheter mitral valve repair devices after a UK court shot down a bid from Abbott for a preliminary injunction. In the suit, filed on January 28, Abbott claimed that Edwards is infringing on two of […]
Wright Medical creates digital arm, promotes Asper to chief digital officer | Personnel Moves – May 7, 2019
Wright Medical (NSDQ:WMGI) said today that it is creating a new digital division and that it is promoting strategy, tech & corporate dev senior VP Jason Asper to chief digital officer. The new CDO title comes alongside Asper’s existing responsibilities, Amsterdam-based Wright Medical said. The new digital division will focus on the company’s digital surgery strategy […]
Abbott launches smartphone-connected Confirm Rx implantable cardiac monitor
Abbott (NYSE:ABT) said today that it is launching its next-generation, FDA and CE Mark cleared, smartphone-connectable Confirm Rx implantable continuous cardiac monitor. The Chicago-area medical device maker said that the newly launched next-gen Confirm Rx is a paper-clip sized implantable device intended for the remote monitoring of unpredictable heart rhythm problems, and is intended to produce […]
Abbott, DoD & brain injury group to begin testing of concussion blood test
Abbott (NYSE:ABT) yesterday announced that through its partnership with the U.S. Department of Defense and the TRACK-TBI network, it is ready to begin clinical trials of a point-of-care blood test technology to help quickly assess brain injuries. The Chicago-area medical device maker and the DoD began their partnership on the testing technology in 2014. Abbott said […]
Abbott’s Q1 tops estimates
Abbott (NYSE:ABT) beat the consensus forecast today for both its bottom and top lines during the first quarter. The Chicago-area healthcare giant posted profits of $682.0 million, or 38¢ per share, on sales of $7.54 billion for the three months ended March 31, for a bottom-line gain of 60.8% on sales growth of 2.0% compared […]
- 1
- 2
- 3
- …
- 67
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube